Clinical Significance of Plasma CD9-Positive Exosomes in HIV Seronegative and Seropositive Lung Cancer Patients
Foteinos‐Ioannis Dimitrakopoulos(Johns Hopkins University), Malcolm V. Brock(Johns Hopkins University), J. Timothy Sherwood(Mary Washington Hospital), Julie R. Brahmer(Johns Hopkins University), Andrew Yang(Johns Hopkins University), Kristen Rodgers(Johns Hopkins University), Αναστασία Κοττόρου(Johns Hopkins University), Stephen B. Baylin(Johns Hopkins University), Hajime Orita(Juntendo University Hospital), Alicia Hulbert(Johns Hopkins University), Stephen C. Yang(Johns Hopkins University), Georgia-Angeliki Koliou(Hellenic Cooperative Oncology Group), Beverly Lee(Lovelace Respiratory Research Institute)
Cited by 11
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k